Tech Company Financing Transactions
BIO Protocol Funding Round
BIO Protocol closed a $6.9 million venture capital round on 9/17/2025. Backers included Maelstrom and private investors.
Transaction Overview
Company Name
Announced On
9/17/2025
Transaction Type
Venture Equity
Amount
$6,900,000
Round
Undisclosed
Investors
Maelstrom (Arthur Hayes)
Proceeds Purpose
The financing fuels Bio Protocol's expansion into a full-stack platform for AI-driven decentralized science, scientific funding and drug discovery.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
New York, NY Undisclosed
USA
New York, NY Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
BIO connects DeSci's early experimental hubs, using DeFi dynamics & real-world IP to grow an ecosystem of living, adaptive scientific networks.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Paul Kohlhaas
Browse more venture capital transactions:
Prev: 9/17/2025: Synthesize Bio venture capital transaction
Next: 9/17/2025: Overmind venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs